ABSTRACT
Lyme disease is the most commonly reported vector-borne disease in the United States, with >30,000 52 cases reported to CDC annually (1) . In fact, since Lyme disease became reportable in 1992 the number of 53 cases reported to CDC has increased dramatically despite attempts at the federal, state, and local level 54 to prevent this epidemic (2). The Lyme disease spirochete, Borrelia burgdorferi, is transmitted principally 55 by the nymphal stage of the blacklegged tick, Ixodes scapularis, from mid-May to mid-June along the 56
Atlantic seaboard from northern Virginia to Maine, with a smaller focus in the north-central US (3). 57
Approximately 80 million people live in states in the eastern half of the U.S. that contain highly endemic 58
Lyme disease regions. 59
The first line of defense against tick-borne disease is certainly education regarding the risk of disease 60 and the personal protection measures that are available (4). Unfortunately, avoidance of tick infested 61 areas, wearing of protective clothing, and using repellents and frequent tick checks are practiced 62 inconsistently by the public; overall these strategies have not been shown to be effective in blunting the 63
Lyme disease epidemic, except in carefully controlled circumstances (5, 6). Despite a plethora of tick 64 control tools developed by researchers including area-wide acaricides, host-targeted acaricides, 65 landscape modification, and least-toxic biological agents (4), actual proof that tick control can lead to a 66 reduction in the incidence of Lyme disease is limited to a few efforts at deer eradication on islands ( removed from the experiment. Similarly, exposed mice upon which nymphal ticks did not attach and 103 feed were removed from the experiment. 104
Borrelia culturing. Mice were tested for infection with B. burgdorferi as previously described (25). At 1 105 month post nymphal tick removal, mice were sacrificed and ears, urinary bladder, and heart were 106 cultured in BSK medium. Cultures were examined by darkfield microscopy weekly for 4 weeks for the 107 presence of live spirochetes. In addition to culture, a subset of mice was tested for serological reaction 108 to B. burgdorferi. Sera from experimental mice were tested at a dilution of 1:500 for antibody to B. Xenodiagnosis. To further confirm the infection status of mice treated with azithromycin cream, we 115 exposed mice to infected nymphs for 72 hours and then treated them with azithromycin or control 116 cream immediately upon nymphal tick removal. At ca. 3 weeks after the nymphal feeding, 117 xenodiagnostic larval ticks from our uninfected colony were allowed to feed on these test mice, as well 118 as on naïve controls. Larval xenodiagnostic ticks were tested for the presence of spirochetes by PCR at 119 10 days post-larval-feeding as previously described (24). 120
Antibiotic cream. Antibiotic creams were prepared with the assistance of a local pharmacy (Good Day  121 Pharmacy; Loveland, CO 
RESULTS

139
The first trial conducted was a direct comparison of the protection provided by the doxycycline cream to 140 that provided by azithromycin cream ( cream's efficacy rather than try to come up with a doxycycline formulation that gave greater protection. 147
The question of when post-tick-removal azithromycin cream had to be delivered to have maximal 148 benefit was evaluated. A group of mice was treated on the day of tick removal (considered Day 0 for the 149 purpose of this experiment) or on subsequent days up to 2 weeks following tick removal. Azithromycin 150 cream treatment was 100% protective if delivered on Day 0, Day 1, Day 2, or Day 3 following tick 151 removal (Table 2) . Although the level of protection fell off somewhat to 74% if delivered >4 days 152 following tick removal, it was still at the 74% protective level even at 2 weeks following tick removal. 153
The next series of experiments was aimed at determining whether the azithromycin cream had to be 154 delivered directly to the site of the tick bite or could be delivered to the skin at a distal site. In 155 experiments where a distal site was treated, mice were shaved on their belly and cream delivered to this 156 ventral location as opposed to the dorsal location where the tick capsule was originally placed. We also 157 tested whether ingestion of the antibiotic cream during mouse grooming played a role in the efficacy of 158 treatment. In these experiments a capsule was left in place and the cream was placed inside the capsule 159 where it could not be groomed off by the mice. The capsule was left for 24 hours either at the tick bite 160 site or the distal location on the ventral side of the mouse. It did not matter whether the treatments 161 were placed at the tick-bite-site or the distal location (Table 3) . Where grooming was allowed, 100% of 162 mice treated at the tick-bite-site and 100% of mice treated at the distal location were protected. Where 163 grooming was not allowed, 92% of mice were protected when treated at the tick-bite-site and 100% of 164 on November 12, 2017 by guest http://aac.asm.org/ Downloaded from mice were protected when treated at the distal location. In all, only 1 out of 38 treated mice in this 165 experiment were not protected from infection. 166
To confirm culture results, sera from 10 mice judged to be infected by culture and 27 mice judged to be 167 negative on culture were selected from the overall dataset and tested for evidence of antibodies to B. 168 burgdorferi by MarBlot. All 10 mice judged to be positive via culture had a positive serological result, 169 and all 27 mice judged to be negative via culture had a negative serological result (data not shown). 170
A total of 10 mice treated with azithromycin were subject to feeding by xenodiagnostic larval ticks; 118 171 xenodiagnostic larvae derived from these mice were all negative for spirochete DNA upon PCR 172 examination (Table 4) . Similarly, 4 naïve control mice produced a total of 39 ticks negative for 173 spirochetes on PCR examination. In contrast 47/47 larval ticks (100%) fed on 4 positive mice treated 174 with control cream proved positive for spirochetal DNA on PCR examination. 175
DISCUSSION
176
Previous experiments with azithromycin have demonstrated that >4% topical creams can provide 100% 177 protection when applied to mice twice daily for 3 days (19). The current work extends these 178 observations and demonstrates that a single application of 4% azithromycin cream can be 100% 179 protective when applied within the first 3 days following tick bite in a murine model system. 180
Interestingly, a commercially available 2% erythromycin topical ointment failed to protect mice against 181 tick transmitted infection with B. burgdorferi (20) . At present, we don't know whether azithromycin is 182 much more effective than the closely related macrolide antibiotic erythromycin, or whether the 183 difference in the concentration of the drug is a key element in their respective success. Azithromycin has 184 long been known to more active against certain gram negative bacteria than is erythromycin (26). 185
Our results with doxycycline prophylaxis in our murine model system have been mixed. Single dose oral 186 doxycycline given by gavage has resulted in disappointing levels of prophylaxis, demonstrating 20-43% 187 protection (15, 16). In contrast, a slow release doxycycline injectable gel that continues to release 188 doxycycline into the bloodstream over several weeks gave 100% protection (15). Protection afforded by 189 oral doxycycline in our murine model was increased to 74% only by delivering the drug twice daily and 190 delivering it on the day ticks were removed (17). Results with topical applications of doxycycline and 191 tetracycline have been inconsistent. Shih and Spielman (18) found doxycycline to be completely 192 protective but did not give details of this experiment. They found tetracycline to be protective only 193 when delivered for 3 days as compared to ineffective results when given for a single day. Wormser et al. 194 (20) found a 3% tetracycline commercial preparation to be ineffective in providing prophylaxis for tick-195 transmitted B. burgdorferi in a murine model. In addition, our experiments in the current study found 196 single topical applications of 4% doxycycline to provide no protection against tick-transmitted infection 197 with B. burgdorferi, even when delivered on the day of tick removal. 
